Frequently Asked Questions. (Version # 3-November 2014)

Similar documents
Provincial Surveillance Protocol for Clostridium difficile infection

Checklists for Preventing and Controlling

HCAI Local implementation team action plan

Clostridium difficile Infection (CDI)

HRET HIIN MEASUREMENT MATTERS: Ground-breaking CDI Practices with Flowers Hospital in Alabama. June 5, :00 p.m. 1:00 p.m.

Clostridium difficile Infection (CDI) Trigger Tool

Enhanced Surveillance of Clostridium difficile Infection in Ireland

Investigating Clostridium difficile Infections

Provincial Surveillance

Montefiore s Clinical Microbiology Lab: Taking Aim at an Urgent Threat

The Core Elements of Antibiotic Stewardship with CMS and QAPI Updates

Antimicrobial Stewardship Program in the Nursing Home

Clostridium difficile

Root Cause Analysis Investigation Report. Clostridium Difficile Ian Monro Ward. The Royal National Orthopaedic Hospital

Root Cause Analysis Investigation Report. The Royal National Orthopaedic Hospital

Includes GP flow chart & out of hours protocols. Page 1 of 11

Antibiotic Stewardship Program (ASP)

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions

Core Elements for Antibiotic Stewardship in Nursing Homes

Clostridium difficile Infection (CDI) Surveillance: Application of the Case Definition in a Regional Health Authority in BC

Alabama Medicaid Pharmacist

Clostridium difficile Infection (CDI) Trigger Tool

C. difficile Infection and C. difficile Lab ID Reporting in NHSN

Guidelines for the Management of C. difficile Infections in. Healthcare Settings. Saskatchewan Infection Prevention and Control Program November 2015

Preventing Hospital Acquired Infections: Clostridium difficile

Drilling Down to Defeat Clostridium difficile. Kathy Mathews, RN Infection Preventionist Sonoma Valley Hospital February 24, 2017

BEHAVIORAL HEALTH & LTC. Mary Ann Kellar, RN, MA, CHES, IC March 2011

CMS and NHSN: What s New for Infection Preventionists in 2013

POLICIES & PROCEDURES. Number: Clostridium difficile. Authorization: SHR Infection Prevention & Control Committee Facility Board of Directors

Nursing Home Antimicrobial Stewardship Guide Implement, Monitor, & Sustain a Program

Clostridium difficile Infection (CDI) Surveillance Report: Saskatchewan

The Core Elements of Antibiotic Stewardship for Nursing Homes

Core Elements of Antibiotic Stewardship for Nursing Homes

CDI Preventing and Managing Clostridium Difficile - A Provider's Perspective

Nursing Home Training Sessions Session 5: Clostridium difficile Part One: Clinical Overview

Antibiotics - Are they OVERUSED? 4/6/2018. Antibiotic Stewardship Key Clinical Strategies for Successful Outcomes. Pathway Health 1.

Decreasing Nosocomial C. diff

SURVEILLANCE PROTOCOLS CLOSTRIDIUM DIFFICILE INFECTION (CDI) PROVINCIAL SURVEILLANCE PROTOCOL. IPC Surveillance and Standards

CLOSTRIDIUM DIFFICILE A MULTI-FACETED ANALYSIS

August 22, Dear Sir or Madam:

Nursing Home Online Training Sessions Session 5: Clostridium difficile Part One: Clinical Overview

Outbreak Management. Gastroenteritis Outbreak Protocol

HEI self-assessment. Completing the self-assessment - Guidance to NHS boards

This paper provides detail of actions to reduce the incidence of Clostridium difficile at Airedale NHS Foundation Trust (ANHST).

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13

Understanding Antimicrobial Stewardship: Is Your Organization Ready? A S H LEIGH MOUSER, PHARM D, BCPS

Running head: DATA COLLECTION AND ANALYSIS IN SURVEILLANCE AND 1

August 15, Dear Mr. Slavitt:

The Business of Antimicrobial Stewardship

CoG (04/17) Item 19. Council of Governors. Item for Information. C difficile Action Plan. To note the report. DATE 11 April 2017 REPORT FOR SUBJECT

C.difficile Associated Disease: A Financial Burden Analysis Dr. Ralf-Peter Vongerg, Hanover Medical School A Webber Training Teleclass

IMPROVEMENT IN PATIENT MANAGEMENT THROUGH THE USE OF A Clostridium difficile PCR REAL TIME STAND ALONE TEST IN ACUTE HOSPITAL SETTING

Infectious EUH Learning Activities:

Using Electronic Health Records for Antibiotic Stewardship

Reducing Clostridium Difficile

Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update

HSE West, Mid-Western Regional Hospitals, Limerick, Guidelines for The Management of Clostridium Difficile, MGIP&C 09/10, Revision 02, 09/12 pg 1 of

Clostridium difficile Infections (CDI): Opportunities for Prevention. Linda Savage, RN, BSN, CDONA/LTC QI Specialist, Telligen March 23, 2016

Successful Strategies to Reduce Clostridium difficile

The Urine Dipstick: A Quick Way To Over-Treat! Ann McFeeters, RN Infection Control Practitioner September 26, 2012

C. difficile INFECTIONS

Thank you for spending your valuable time with us today. This webinar will be recorded for your convenience.

Influence of Patient Flow on Quality Care

Today s webinar will begin in a few minutes.

IHI Expedition. Antibiotic Stewardship Session 2: Promoting a Culture for Optimal Antibiotic Use. April 3, Diane Jacobsen, MPH Loria Pollack, MD

CLOSTRIDIUM DIFFICILE INFECTION PREVENTION AND CONTROL POLICY

Infection Prevention & Control Engaging Stakeholders

How to Add an Annual Facility Survey

Protocol for the Prevention and Management of Clostridium difficile.

Healthcare associated infections across the health and social care community

Leadership Engagement in Antimicrobial Stewardship

Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014

Hospital Acquired Clostridium Difficile Infection Prevention

Harrisburg, Pennsylvania. Assignment Description

Evidence Based Practices to Prevent HAIs/CAUTI and Improve Resident Safety

abc INFECTION CONTROL STRATEGY

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative

Clostridium difficile policy

Influence of Patient Flow on Quality Care

IHI Expedition. Antibiotic Stewardship Session 3: Our Learning Journey: IHI & CDC Antibiotic Stewardship Partnership.

San Francisco General Hospital INFECTION CONTROL

Monitoring and Traceability Material Tracking Efficacy Monitoring Adverse Event Reporting

PGY1: Pediatric Infectious Diseases Riley Hospital for Children Indiana University Health

SPONSORED. In Support of Increasing Awareness of VAP Bundles to Prevent Ventilator Associated Pneumonia in the Hospital Setting

Control of Clostridium difficile Infection (CDI) Outbreaks in Hospitals A Guide for Hospital and Health Unit Staff

Enhanced Recovery Implementing Meaningful Change

LABORATORY IDENTIFIED (LABID) EVENT REPORTING MRSA BACTEREMIA AND C. DIFFICILE. National Healthcare Safety Network (NHSN)

What is it, Why is it Important and What is Your Role? Aug 16, 2017

PATIENTS WITH DIARRHOEA

LABORATORY-IDENTIFIED (LABID) EVENT REPORTING MRSA BACTEREMIA AND C. DIFFICILE. National Healthcare Safety Network (NHSN)

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

Thank You for Joining!

AHA/HRET HEN 2.0 PREVENTING AND DIAGNOSING C. DIFFICILE INFECTIONS: PRESERVE, PREDICT, PROTECT. December 14, :00 a.m. 12:30 p.m.

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery

Use of Novel Approaches to Reduce Clostridium Difficile in an Inner City Hospital. Abstract

Organizational Structure Ossama Rasslan

IT TAKES A VILLAGE TO IMPLEMENT CATHETER ASSOCIATED URINARY TRACT INFECTION (CAUTI) PREVENTION

Clostridium difficile

Healthcare Acquired Infections

Overview of Revised LTC Surveillance Definitions

Transcription:

MSH-UHN First Episode C.difficile (CDI) Management Algorithm 1) Why was this algorithm developed? Frequently Asked Questions (Version # 3-November 2014) In a review of UHN and MSH data, we found that one new case of nosocomial CDI occurs across all sites every two days. A chart audit demonstrated variation in that management of CDI within the different specialties providing patient care, and that this has contributed to critical incidents. The objective of the CDI management algorithm is to standardize care of patients that are admitted or anticipated to be admitted to the hospital with a diagnosis of CDI for the purpose of providing best possible patient care. 2) How was this algorithm developed? A large stakeholder group consisting of representation from diverse disciplines across Mt. Sinai Hospital (MSH) and University Health Network (UHN) worked with a small project working group over a ten-month period to develop and refine the algorithm. Consultation was obtained from different departments and divisions across MSH and UHN including Emergency Medicine, Gastroenterology, General Surgery, Infection (Prevention and) Control, Infectious Diseases, Microbiology, Nursing, Clinical Dietitians, and Pharmacy. The draft algorithm was reviewed by members of the MSH-UHN Antimicrobial Stewardship Program to integrate the appropriate antibiotic recommendations. The algorithm was then taken to various committees across hospital sites to obtain feedback and approval. 3) How will this algorithm improve patient outcomes? The ability to intervene promptly, standardize care, and ensure appropriate monitoring is fundamental to beneficial patient outcomes. This algorithm has been developed with an interdisciplinary approach combined with antimicrobial stewardship strategies. 4) How will the algorithm be evaluated for its effectiveness within the clinical setting? We will monitor the algorithm in practice throughout the months post-implementation. An Infectious Diseases Resident, Dr. Shaqil Peermohamed, will be evaluating the impact of the algorithm on practice. In doing so, the following patient outcomes will be examined: diseasefree survival at 60 days, length of hospital stay and rates of severe adverse events such as ICU admission, morbidity and mortality. Page 1 of 5

5) Why is abdominal x-ray not present in the management recommendations within the algorithm? With broad consultation involving the project stakeholders, it was decided that routinely utilizing abdominal x-rays in the treatment and management of CDI patients does not have a great clinical impact on the care decisions made by clinicians. We therefore recommend utilizing CT scans for clinical decisions when patients with CDI have severe or complicated/fulminant disease. 6) How were the risk factors for CDI within the algorithm established? The risk factors within the algorithm were established with literature review, broad consultation from the project stakeholders, and based on the results of the multi-site chart audit. The chart audit completed by the project team highlighted present gaps in care related to the management of CDI patients and the common medical comorbidities linked with CDI. 7) How do I know that a patient has diarrhea? There is no perfect and practical definition of diarrhea. In most cases, for the purposes of CDI, you know the patient has diarrhea if their bowel pattern is outside of their norm, if they are having numerous watery bowel movements, and if the stool specimen takes the shape of the specimen container. 1 8) What is the best strategy for testing stool for CDI? Testing for CDI or its toxins should be performed only on unformed or diarrheal stool, unless there is an ileus suspected due to C. difficile. Neither testing for asymptomatic patients nor for a patient s cure are encouraged 2 9) What role does Infection (Prevention and) Control have in the algorithm? Both Infection Control at MSH and Infection Prevention and Control (IPAC) at UHN were involved throughout the development of the algorithm. The prompt detection of patients with diarrhea, enhanced precautions, attention to environmental cleaning and good hand hygiene are very important steps in caring for patients with CDI. 10) Why does this algorithm not address the management of patients with recurrent CDI? The intent of the algorithm is to be a simple tool that can be utilized across hospital sites and on different inpatient units. The algorithm is specific to the first episode of CDI and there are future plans to develop an algorithm that guides the management of recurrent episodes. At present, recurrent CDI should prompt strong consideration for consultation from Infectious Diseases. Page 2 of 5

11) How does this algorithm assist clinicians when they are caring for patients with atypical cases of CDI? One of the key aspects of the algorithm is the involvement of consulting teams early in the course of infection to improve patient outcomes. In doing so, the patients that have atypical infections will be managed promptly by a diverse clinical team and treated appropriately. Another key aspect of the algorithm that will assist in managing atypical cases is the importance of close monitoring and continued follow-up until clinical resolution or discharge. 12) What role do RNs have in the algorithm? One of the main goals of the algorithm is to empower RNs or Patient Care Coordinators to oversee the algorithm in practice and offer guidance in some important aspects of clinical decision making. In following the algorithm, RNs or Patient Care Coordinators will be able to continue to assess and re-assess the patient when appropriate and ensure that all clinicians involved in the care of the patient are continually engaged. 13) Why were probiotics not addressed in the algorithm? There is conflicting evidence regarding the effectiveness of probiotics in preventing CDI 2. Additionally, this algorithm focuses on treatment, rather than prevention. The algorithm does include recommendations to consult a Registered Dietitian if appropriate in the care of the patient. 14) What special considerations need to be made for patients that are discharged on vancomycin? Prescribers should complete Exceptional Access Program (EAP) documentation for oral vancomycin prior to patient discharge. Further information regarding EAP can be found at: http://www.health.gov.on.ca/en/pro/programs/drugs/eap_criteria_list.aspx References: 1) Baqui AH, Black RE, Yunus M, Hoque AR, Chowdhury HR, Sack RB. Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol. 1991; 20:1057-63. 2) Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald CL et al/clinical practice guidelines for Clostridium difficile infection in adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America. Infection Control Hosp Epidemiol 2010; 3(5). Page 3 of 5

The algorithm was developed in consultation with: Shohreh Abrouie, Clinical Nurse Specialist, Mt. Sinai Hospital Marcia Cameron, Patient Care Coordinator, University Health Network Julie Cepo, Registered Dietician, Mt. Sinai Hospital Ingrid Daley, Patient Care Coordinator, University Health Network Dina D Agostina-Rose, Senior Clinical Director, University Health Network Dr. James Downar, Palliative Care and Intensive Care Physician, University Health Network Dr. Kevin Duplisea, Antimicrobial Stewardship Program Pharmacotherapy Specialist, University Health Network Dr. David Dushenski, Deputy Director of the Emergency Department and Emergency Medicine Physician, Mt. Sinai Hospital Dr. Susy Hota, Infection Prevention and Control Physician, University Health Network Dr. Rupert Kaul, Infectious Disease Physician, University Health Network Dr. Camille Lemieux, Associate Director Infection Prevention and Control, University Health Network Dr. Tony Mazzulli, Microbiologist-in-Chief, Mt. Sinai Hospital Dr. Allison McGeer, Director of Infection Control Department, Mt. Sinai Hospital Mark McIntyre, Clinical Practice Leader Department of Pharmacy, Mt. Sinai Hospital Cindy Miller, Registered Dietician, Mt. Sinai Hospital Dr. Matthew Morgan, Vice President, Patient Experience and Outcomes, Mt. Sinai Hospital Dr. Andrew Morris, Director of Antimicrobial Stewardship Program, Mt. Sinai Hospital and University Health Network Emily Musing, Executive Director of Pharmacy, Clinical Risk and Quality, University Health Network Yoshi Nakamachi, Program Manager, Antimicrobial Stewardship Program, University Health Network and Mt. Sinai Hospital Dr. Susan Poutanen, Microbiologist and Infectious Disease Consultant, Mt. Sinai Hospital Dr. Fayez Quereshy, Surgical Oncologist and Minimally Invasive Surgery Physician, University Page 4 of 5

Health Network Joy Richards, Vice President Health Professions and Chief Nurse, University Health Network Elke Ruthing, Manager Patient and Family Education Program, University Health Network Dr. Jeff Singh, Critical Care Physician, University Health Network Sarah West, Project Manager, Antimicrobial Stewardship Program, Mt. Sinai Hospital Dr. Adam Weizman, Gastroenterologist, University Health Network Gary Wong, Pharmacy Practice Leader, University Health Network Andrew Wyllie, Drug Information Pharmacist, Mt. Sinai Hospital Samira Zanjani, Patient Care Coordinator, University Health Network The algorithm has been reviewed by the following committees: Pharmacy and Therapeutics, Mt. Sinai Hospital Pharmacy and Therapeutics, University Health Network Infection Prevention and Control Committee, University Health Network Professional Nursing Practice Committee, University Health Network Quality of Care Committee, University Health Network Infectious Disease Department Business Meeting, University Health Network Patient Care Coordinator Committee, University Health Network Associated Links: 1) Antimicrobial Stewardship Program webpage: antimicrobialstewardship.com 2) The First Episode Clostridium Difficile Infection (CDI) Management Algorithm: http://www.antimicrobialstewardship.com/sites/default/files/cdi_algorithm-final- _oct_011.pdf 3) CDI algorithm e-learning at Mt. Sinai Hospital: http://info2/departments/informatics/elearning 4) CDI algorithm e-learning at the University Health Network: https://rod.sumtotalsystems.com/uhn/app/sys_login.aspx Page 5 of 5